Transplantation Proceedings
Volume 41, Issue 9 , Pages 3531-3536 , November 2009

The Cost-Effectiveness of Organ Preservation Methods in Renal Transplantation: US Projections Based on the Machine Preservation Trial

  • S.S. Garfield

      Affiliations

    • Bridgehead International, Wayland, Massachusetts, USA
    • ,
  • A.W. Poret

      Affiliations

    • Bridgehead International, Wayland, Massachusetts, USA
    • ,
  • R.W. Evans

      Affiliations

    • TransplantProfessionals.com, LLC, Rochester, Minnesota, USA
    • Corresponding Author InformationAddress reprint requests to Roger W. Evans, PhD, TransplantProfessionals.com, LLC, 2251 Baihly Hills Drive Southwest, Rochester, MN 55902-1311

References 

  1. Evans RW, Manninen DL, Garrison LP, et al. The quality of life of patients with end-stage renal disease. N Engl J Med. 1985;312:553
  2. Gorzalez-Perez JG, Vale L, Stearns SC, et al. Hemodialysis for end-stage renal disease: a cost-effectiveness analysis of treatment options. Int J Technol Assess Health Care. 2005;21:32
  3. Current U.S. kidney transplant waiting list: Based on OPTN data as of March 20, 2009. Richmond, VA: United Network for Organ Sharing; March, 2009;http://www.optn.org/latestData/step2.aspAccessed on March 25, 2009
  4. Audard V, Matignon M, Dahan K, et al. Renal transplantation from extended criteria cadaveric donors: problems and perspectives overview. Transpl Int. 2008;21:11
  5. Tutte-Newhall JE, Krishnan SM, Levy MF, et al. Organ donation and utilization in the United States: 1998–2007. Am J Transplant. 2009;9:879
  6. Pascual J, Zamora J, Pirsch JD. A systematic review of kidney transplantation from expanded criteria donors. Am J Kidney Dis. 2008;52:553
  7. NIH Publication No. 08-3176 In: U.S. Renal Data System, USRDS 2008 Annual Data Report: Atlas of Chronic Kidney Disease and End-stage Renal Disease in the United States. Volume 3:Bethesda, MD: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2008;p. 115;Section F
  8. Stratta R, Moore P, Farney A, et al. Influence of pulsatile perfusion preservation on outcomes in kidney transplantation from expanded criteria donors. J Am Coll Surg. 2007;204:873
  9. Moers C, Smits JM, Maathuis M-HJ, et al. Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med. 2009;360:7
  10. Wight J, Chilcott J, Holmes M, et al. The clinical and cost-effectiveness of pulsatile machine perfusion versus cold storage of kidneys for transplantation retrieved from heart-beating and non-heart-beating donors. Health Technol Assess. 2003;7:1
  11. Light JA, Gage F, Kowalski AE, et al. Immediate function and cost comparison between static and pulsatile preservation in kidney recipients. Clin Transplant. 1996;10:233
  12. Buchanan PM, Lentine KL, Burroughs TE, et al. Association of lower costs of pulsatile machine perfusion in renal transplantation from expanded criteria donors. Am J Transplant. 2008;8:2391
  13. In:  Haddix AC,  Teutsch SM,  Shaffer PA editor. Prevention Effectiveness: A Guide to Decision Analysis and Economic Evaluation. New York: Oxford University Press; 1996;
  14. Petitti DB. Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis: Methods for Quantitative Synthesis in Medicine. New York: Oxford University Press; 1994;
  15. Matas A, Schnitzler M. Payment for living donor kidneys: a cost-effectiveness analysis. Am J Transplant. 2003;4:216
  16. Hirth RA, Held PJ, Orzol SM, et al. Practice patterns, case mix, Medicare payment policy, and dialysis facility costs. Health Serv Res. 1999;33:1567
  17. Current U.S. kidney transplant cost data as of March, 2009. http://www.usrds.org/2008/ref/K_Economic_costs_of_ESRD_08.pdfAccessed March 30, 2009
  18. Notification of change of interim reimbursement rates, memorandum dated 12/20/07 to go into effect 01/01/08. Chattanooga, TN: Riverbend Medicare Fiscal Intermediary; 2007;http://www.rgbagov.com/Providers/OPO-HCL/Audit-Reimbursement/Rates/2008rates.xlsAccessed March 25, 2009
  19. In: Report to the Congress: Medicare Payment Policy. Washington, DC: Medicare Payment Advisory Commission; March, 2009;p. 45;85
  20. End-Stage Renal Disease (Characteristics of Kidney Transplant Recipients, Frequency of Transplant Failures, and Cost to Medicare. Report No. GAO-07-1117). Washington, DC: US Government Accountability Office; September 2007;
  21. Evans RW. Economic, actuarial, and contracting perspectives on liver transplantation. In:  Maddrey WC,  Schiff ER,  Sorrell MF editor. Transplantation of the Liver. Philadelphia: Lippincott Williams & Wilkins; 2000;p. 479
  22. Evans RW. Financial, economic and insurance issues pertaining to intestinal transplantation: when is too much not enough?. In:  Langnas AN,  Goulet O,  Quigley EMM, et al. editor. Intestinal Failure: Diagnosis, Management and Transplantation. Malden, MA: Blackwell Publishing; 2008;p. 363
  23. Groen H, Moers C, Smits JM, et al. Long-term cost-effectiveness of hypothermic perfusion versus cold storage in kidney transplantation. Am J Transplant. 2009;9(suppl 2):227
  24. An introduction to Cochrane reviews and The Cochrane Library. Oxford, England: The Cochrane Collaboration; 2009;http://www.cochrane.org/reviews/clibintro.htmAccessed March 25, 2009
  25. Leaf A. Cost effectiveness as a criterion for Medicare coverage. N Engl J Med. 1989;321:898
  26. Min DeParle N-A, Shalala DE. Medicare program; criteria for making coverage decisions. Fed Register. 2000;65:31124
  27. Garber AM, Tunis SR. Does comparative-effectiveness research threaten personalized medicine?. N Engl J Med. 2009;360:1925
  28. Avorn J. Debate about funding comparative-effectiveness research. N Engl J Med. 2009;360:1927
  29. Naik AD, Peterson LA. The neglected purpose of comparative-effectiveness research. N Engl J Med. 2009;360:1929
  30. Bloche MG. Consumer-directed health care. N Engl J Med. 2006;355:1756
  31. Robinson JC. Managed consumerism in health care. Health Aff. 2005;24:1478
  32. Wilensky GR. Consumer-driven health plans: early evidence and potential impact on hospitals. Health Aff. 2006;25:174

 The authors are paid consultants to Organ Recovery Systems, Inc, 2570 E Devon Avenue, Des Plaines, IL 60018 USA. Organ Recovery Systems, Inc. has funded the research reported here.

PII: S0041-1345(09)01579-6

doi: 10.1016/j.transproceed.2009.10.004

Transplantation Proceedings
Volume 41, Issue 9 , Pages 3531-3536 , November 2009

Article Tools